Driving impairment and altered ocular activity under the effects of alprazolam and alcohol: A randomized, double-blind, placebo-controlled study

被引:5
作者
Aitken, Blair [1 ]
Hayley, Amie C. [1 ,2 ]
Ford, Talitha C. [1 ,3 ]
Geier, Lauren [4 ]
Shiferaw, Brook A. [1 ,2 ,5 ]
Downey, Luke A. [1 ,2 ,6 ]
机构
[1] Swinburne Univ Technol, Ctr Human Psychopharmacol, Hawthorn, Vic, Australia
[2] Austin Hlth, Inst Breathing & Sleep IBAS, Heidelberg, Vic, Australia
[3] Deakin Univ, Cognit Neurosci Unit, Geelong, Vic, Australia
[4] Forens Sci South Australia, Adelaide, Australia
[5] Seeing Machines, Canberra, ACT 2612, Australia
[6] Swinburne Univ Technol, Ctr Mental Hlth & Brain Sci, Hawthorn, Vic 3122, Australia
基金
英国医学研究理事会;
关键词
Alcohol; Alprazolam; Driving; Gaze entropy; Ocular monitoring; Road safety; PERFORMANCE; PREVALENCE; RISK; BENZODIAZEPINES; RESPONSIBILITY; PSYCHOMOTOR; DRUGS;
D O I
10.1016/j.drugalcdep.2023.110919
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Alprazolam, also known by trade-name Xanax, is regularly detected along with alcohol in blood samples of drivers injured or killed in traffic collisions. While their co-consumption is principally legal, policy guidelines concerning fitness-to-drive are lacking and methods to index impairment are underdeveloped. Methods: In this randomized, double-blind, placebo-controlled, crossover trial, we examined whether legally permissible levels of alcohol [target 0.04% blood alcohol concentration (BAC)], alprazolam (1 mg), and their combination impacts driving performance, and whether driving impairment can be indexed by ocular activity. Participants completed a test battery consisting of a 40-minute simulated highway drive with ocular parameters assessed simultaneously, the Karolinska Sleepiness Scale, and a confidence to drive assessment following four separate treatment combinations. The predictive efficacy of ocular parameters to identify alcohol and alprazolam-related driving impairment was also examined.Results: Among 21 healthy, fully licensed drivers (37% female, mean age 28.43, SD & PLUSMN; 3.96), driving performance was significantly impacted by alprazolam, alcohol, and their combination. Linear regression models revealed that the odds of an out-of-lane event occurring increased five-fold under the influence alprazolam alone and when combined with alcohol. An increase in gaze transition entropy (GTE) demonstrated the strongest association with the odds of an out-of-lane event occurring in the same minute, with both microsleeps and fixation rate achieving moderate accuracy across treatments.Conclusions: Alprazolam and alcohol, alone and in combination, impaired select aspects of vehicle control over time. GTE, microsleeps, and fixation rate show potential as real-time indicators of driving impairment and crash risk associated with alcohol and alprazolam consumption.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Escitalopram in Adolescents With Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study [J].
Strawn, Jeffrey R. ;
Mills, Jeffrey A. ;
Schroeder, Heidi ;
Mossman, Sarah A. ;
Varney, Sara T. ;
Ramsey, Laura B. ;
Poweleit, Ethan A. ;
Desta, Zeruesenay ;
Cecil, Kim ;
DelBello, Melissa P. .
JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
[42]   A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis [J].
Donders, Gilbert G. G. ;
Guaschino, Secondo ;
Peters, Klaus ;
Tacchi, Raffaella ;
Lauro, Vittoria .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 120 (02) :131-136
[43]   Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial [J].
Senturk, Mehmet B. ;
Cakmak, Yusuf ;
Yildiz, Gazi ;
Yildiz, Pinar .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 287 (04) :641-645
[44]   Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease [J].
Suzuki, Masahiko ;
Yoshioka, Masayuki ;
Hashimoto, Masaya ;
Murakami, Maiko ;
Noya, Miki ;
Takahashi, Daisuke ;
Urashima, Mitsuyoshi .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 97 (05) :1004-1013
[45]   Baclofen as a Pharmacotherapy for the Treatment of Concurrent Alcohol and Nicotine Dependence: A Double-blind, Placebo-controlled, Randomized Trial [J].
Farokhnia, Mehdi ;
Edwards, Steven M. ;
Bollinger, Jared ;
Amodio, Jonathan ;
Zywiak, William H. ;
Tidey, Jennifer W. ;
Swift, Robert M. ;
Kenna, George A. ;
Leggio, Lorenzo .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 :S340-S340
[46]   Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial [J].
Melby, Katrine ;
Grawe, Rolf W. ;
Aamo, Trond O. ;
Salvesen, Oyvind ;
Spigset, Olav .
DRUG AND ALCOHOL DEPENDENCE, 2019, 197 :95-101
[47]   Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol [J].
Thompson, I. ;
Williams, G. ;
Caldwell, B. ;
Aldington, S. ;
Dickson, S. ;
Lucas, N. ;
McDowall, J. ;
Weatherall, M. ;
Robinson, G. ;
Beasley, R. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (09) :1299-1308
[48]   Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study [J].
Kumarathurai, Preman ;
Anholm, Christian ;
Larsen, Bjorn S. ;
Olsen, Rasmus Huan ;
Madsbad, Sten ;
Kristiansen, Ole ;
Nielsen, Olav W. ;
Haugaard, Steen B. ;
Sajadieh, Ahmad .
DIABETES CARE, 2017, 40 (01) :117-124
[49]   Effects of Sulfate-Rich Mineral Water on Functional Constipation: A Double-Blind, Randomized, Placebo-Controlled Study [J].
Naumann, Johannes ;
Sadaghiani, Catharina ;
Alt, Felix ;
Huber, Roman .
FORSCHENDE KOMPLEMENTARMEDIZIN, 2016, 23 (06) :356-363
[50]   Effects of Phyllanthus amarus PHYLLPROTM leaves on hangover symptoms: a randomized, double-blind, placebo-controlled crossover study [J].
George, Annie ;
Udani, Jay K. ;
Yusof, Ashril .
PHARMACEUTICAL BIOLOGY, 2019, 57 (01) :145-153